The Valley Desk

NCT00243542 · Interventional trial

Phase IV Study to Gather More Information About the Safety of ACZONE Gel, 5% in Treating Subjects With Acne Who Have G6PD Deficiency

Overall registry status Completed

Phase 4

Conditions Acne Vulgaris

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov